DXCM Trading Analysis - 09/11/2026 03:51 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for DXCM include:

• DXCM has been in focus due to its role in the continuous glucose monitoring (CGM) market, with growing competition from other medical device companies.
• The company has seen increased adoption of its CGM systems, which could positively impact revenue growth.
• There have been concerns about the impact of regulatory changes on the medical device industry, which could affect DXCM's business operations.

These headlines suggest that DXCM is operating in a dynamic and competitive environment, with both opportunities and challenges that could impact its stock performance.

Fundamental Analysis:

Based on the provided fundamentals data:

• Revenue: $4,969,200,000
• Trailing EPS: $2.52
• Trailing P/E: 33.54
• Price-to-Book: 25.69
• Debt-to-Equity: 1.46
• Return on Equity (ROE): 38.14%
• Gross Margin: 62.47%
• Operating Margin: 22.92%
• Profit Margin: 20.12%

The company's fundamentals indicate a strong revenue base, with a high profit margin and ROE. However, the P/E ratio and debt-to-equity ratio may suggest some valuation concerns.

Current Market Position:

Current price: $83.18

Recent price action: The stock has been trading in a range, with a recent low of $82.83 and a high of $85.82.

Key support and resistance levels: $82.42 (50-day SMA) and $88.72 (20-day SMA).

Intraday momentum: The stock is showing a neutral intraday momentum, with a slight upward trend.

Technical Analysis:

The technical indicators suggest that the stock is oversold (RSI 18.75) and has a bullish MACD signal.

The 50-day SMA is at $82.42, which could act as a support level, while the 20-day SMA is at $88.72, which could act as a resistance level.

True Sentiment Analysis (Delta 40-60 Options):

Overall options flow sentiment: Balanced

Call vs Put dollar volume: Calls $833,145 vs Puts $1,106,940

The pure directional positioning suggests a neutral near-term expectation.

Key Price Levels (observational only):

25-Day Price Forecast:

DXCM is projected for $80.00 to $90.00

Based on current technical trends, momentum, and indicators, the stock is expected to trade within this range.

Defined Risk Strategy Recommendations:

Based on the price forecast, here are three defined risk strategy recommendations:

2. Buy the 85.00 strike call and sell the 90.00 strike call (Bull Call Spread) for the October 16 expiration date. This strategy benefits from a price increase towards $90.00.
3. Sell the 82.00 strike put and buy the 80.00 strike put (Bear Put Spread) for the October 16 expiration date. This strategy benefits from a price decrease towards $80.00.
4. Sell the 85.00 strike call, buy the 90.00 strike call, sell the 80.00 strike put, and buy the 75.00 strike put (Iron Condor) for the October 16 expiration date. This strategy benefits from a stable price around $85.00.

Risk Factors:

• Technical warning signs: RSI oversold condition may lead to a bounce-back.
• Sentiment divergences: Options flow sentiment is balanced, which may not align with the technical indicators.
• Volatility and ATR considerations: Recent volatility may impact the strategy performance.

Summary & Conviction Level:

Overall bias: Neutral

Conviction level: Medium

One-line trade idea: Consider defined risk strategies based on the projected price range.